SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950135-07-006921
Filing Date
2007-11-09
Accepted
2007-11-09 17:06:14
Documents
5
Period of Report
2007-09-30

Document Format Files

Seq Description Document Type Size
1 OXIGENE, INC. b67174oie10vq.htm 10-Q 264712
2 EX-10.3 SEPARATION AGREEMENT BETWEEN THE COMPANY AND PETER HARRIS, M.D. DATED AU b67174oiexv10w3.htm EX-10.3 44042
3 EX-31.1 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER REQUIRED BY SECTION 302 b67174oiexv31w1.htm EX-31.1 5874
4 EX-31.2 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER REQUIRED BY SECTION 302 b67174oiexv31w2.htm EX-31.2 6222
5 EX-32.1 CERTIFICATION OF CEO AND CFO AS ADOPTED PURSUANT TO SECTION 906 b67174oiexv32w1.htm EX-32.1 4691
  Complete submission text file 0000950135-07-006921.txt   326833
Mailing Address
Business Address 321 ARSENAL STREET WATERTOWN MA 02472 6176737800
OXIGENE INC (Filer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21990 | Film No.: 071232726
SIC: 2836 Biological Products, (No Diagnostic Substances)